General Atlantic LLC Portfolio Holdings

General Atlantic LLC

  • $2.96 Billion
  • Q1 2025

General Atlantic LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $2.96 Billion distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Alignment Healthcare, Inc. with a value of $1.14B, D Local LTD with a value of $533M, Xp Inc. with a value of $407M, Alkami Technology, Inc. with a value of $253M, and Akero Therapeutics, Inc. with a value of $212M.

Examining the 13F form we can see an increase of $172M in the current position value, from $2.79B to 2.96B.

General Atlantic LLC is based out at New York, NY

Below you can find more details about General Atlantic LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.96 Billion
Healthcare: $1.69 Billion
Technology: $811 Million
Financial Services: $407 Million
Consumer Defensive: $51.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.72B
$1.14 Billion 38.31% of portfolio
60,993,323
Q3 2022 Reduced 12.95%
$1.67B
$533 Million 17.98% of portfolio
63,906,695
Q2 2023 Added 3.5%
$8.91B
$407 Million 13.74% of portfolio
29,617,733
Q2 2023 Added 16.98%
$2.48B
$253 Million 8.54% of portfolio
9,645,318
Q4 2024 Reduced 37.85%
$2.55B
$212 Million 7.15% of portfolio
5,233,989
Q1 2024 Added 193.1%
$1.18B
$139 Million 4.7% of portfolio
9,681,818
Q3 2021 Added 545.45%
$573M
$118 Million 3.99% of portfolio
7,531,252
Q1 2024 Added 22.34%
$228M
$51.8 Million 1.75% of portfolio
13,110,492
Q2 2022 Reduced 17.45%
$15.1B
$46.7 Million 1.57% of portfolio
1,500,000
Q2 2020 New
$1.44B
$37.4 Million 1.26% of portfolio
1,261,684
Q2 2024 Reduced 16.26%
$451M
$24.6 Million 0.83% of portfolio
5,324,998
Q3 2021 New
$83.8M
$5.82 Million 0.2% of portfolio
3,825,952
Q4 2024 Added 1,349.22%
Grove Collaborative
-
$0 0.0% of portfolio
-
Q4 2024 Added 164.4%
Wish
-
$0 0.0% of portfolio
-
Q4 2023 Added 0.0%
Acelyrin
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 6.73%

Summary

  • Portfolio
  • No. of Stocks 15
  • Current Value $2.96 Billion
  • Prior Value $2.79 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 14, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track General Atlantic LLC Portfolio

Follow General Atlantic LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Atlantic LLC, based on Form 13F filings with the SEC.

News

Stay updated on General Atlantic LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email